Literature DB >> 30753664

Persistent Underutilization of BRCA1/2 Testing Suggest the Need for New Approaches to Genetic Testing Delivery.

Anne Marie McCarthy1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30753664      PMCID： PMC6695316          DOI： 10.1093/jnci/djz009

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  38 in total

1.  Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.

Authors:  Adam H Buchanan; Santanu K Datta; Celette Sugg Skinner; Gail P Hollowell; Henry F Beresford; Thomas Freeland; Benjamin Rogers; John Boling; P Kelly Marcom; Martha B Adams
Journal:  J Genet Couns       Date:  2015-04-03       Impact factor: 2.537

Review 2.  What characterizes cancer family history collection tools? A critical literature review.

Authors:  J E Cleophat; H Nabi; S Pelletier; K Bouchard; M Dorval
Journal:  Curr Oncol       Date:  2018-08-14       Impact factor: 3.677

3.  BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines.

Authors:  Danielle S Chun; Brygida Berse; Vickie L Venne; Scott L DuVall; Kelly K Filipski; Michael J Kelley; Laurence J Meyer; Michael S Icardi; Julie A Lynch
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

4.  A Comprehensive Program Enabling Effective Delivery of Regional Genetic Counseling.

Authors:  Jubilee Brown; Aly Athens; David L Tait; Erin K Crane; Robert V Higgins; R Wendel Naumann; Lejla Hadzikadic Gusic; Lisa Amacker-North
Journal:  Int J Gynecol Cancer       Date:  2018-06       Impact factor: 3.437

Review 5.  Uptake rates for breast cancer genetic testing: a systematic review.

Authors:  Mary E Ropka; Jennifer Wenzel; Elayne K Phillips; Mir Siadaty; John T Philbrick
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-05       Impact factor: 4.254

6.  Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.

Authors:  Kelly A Metcalfe; Aletta Poll; Robert Royer; Marcia Llacuachaqui; Anna Tulman; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

7.  Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.

Authors:  Leland E Hull; Jennifer S Haas; Steven R Simon
Journal:  Am J Prev Med       Date:  2017-12-11       Impact factor: 5.043

8.  Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.

Authors:  Ranjit Manchanda; Shreeya Patel; Vladimir S Gordeev; Antonis C Antoniou; Shantel Smith; Andrew Lee; John L Hopper; Robert J MacInnis; Clare Turnbull; Susan J Ramus; Simon A Gayther; Paul D P Pharoah; Usha Menon; Ian Jacobs; Rosa Legood
Journal:  J Natl Cancer Inst       Date:  2018-07-01       Impact factor: 13.506

9.  Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trial.

Authors:  Ranjit Manchanda; Kelly Loggenberg; Saskia Sanderson; Matthew Burnell; Jane Wardle; Sue Gessler; Lucy Side; Nyala Balogun; Rakshit Desai; Ajith Kumar; Huw Dorkins; Yvonne Wallis; Cyril Chapman; Rohan Taylor; Chris Jacobs; Ian Tomlinson; Alistair McGuire; Uziel Beller; Usha Menon; Ian Jacobs
Journal:  J Natl Cancer Inst       Date:  2014-11-30       Impact factor: 13.506

10.  Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers.

Authors:  Eli Marie Grindedal; Cecilie Heramb; Inga Karsrud; Sarah Louise Ariansen; Lovise Mæhle; Dag Erik Undlien; Jan Norum; Ellen Schlichting
Journal:  BMC Cancer       Date:  2017-06-21       Impact factor: 4.430
View more
  1 in total

1.  Association between Health Insurance Type and Genetic Testing and/or Counseling for Breast and Ovarian Cancer.

Authors:  Arian Mansur; Fang Zhang; Christine Y Lu
Journal:  J Pers Med       Date:  2022-07-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.